Study #2023-1063
An open-label, single-arm study of autologous anti-HER2 chimeric antigen receptor monocytes (CT-0525), in participants with HER2 over expressing Solid Tumors
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Paula Pohlmann
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-844-996-5012
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.